“…As such, opportunities to prevent or treat opportunistic infections, or to offer psychological support, are missed (World Health Organization, 2016). In Mexico, previous studies have mainly focused on ART discontinuation (Gutiérrez-Gabriel et al, 2019; Pérez-Rodríguez et al, 2016; Pérez-Salgado et al, 2017). Instead, this study distinguished factors that led to HIV care disengagement in the first place—which precludes ART intake—and factors that lead to ART discontinuation, which are inherent to the medicine itself.…”